Literature DB >> 8042990

Calsequestrin is a component of smooth muscles: the skeletal- and cardiac-muscle isoforms are both present, although in highly variable amounts and ratios.

P Volpe1, A Martini, S Furlan, J Meldolesi.   

Abstract

Expression by smooth-muscle cells of calsequestrin (CS), the low-affinity/high-capacity Ca(2+)-binding protein of striated-muscle sarcoplasmic reticulum (SR), has been investigated in recent years with conflicting results. Here we report the purification and characterization from rat vas deferens of two CS isoforms, the first deemed skeletal muscle, the second cardiac type, on account of their N-terminal amino acids and other relevant biochemical and molecular properties. Compared with vas deferens, the smooth muscles from aorta and stomach, in that order, were found to express lower amounts of CS, whereas in the uterus and bladder the protein was not detectable. The ratio between the two CS isoforms was also variable, with the stomach and aorta predominantly expressing the skeletal-muscle type and the vas deferens expressing the two CSs in roughly similar amount. Because of the property of CSs to localize within the skeletal-muscle SR lumen not uniformly, but according to the distribution of their anchorage membrane proteins, the expression of the protein suggests the existence in smooth-muscle cells of discrete endoplasmic-reticulum areas specialized in the rapidly exchanging Ca2+ storage and release, and thus in the control of a variety of functions, including smooth-muscle contraction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8042990      PMCID: PMC1137104          DOI: 10.1042/bj3010465

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

Review 1.  Cellular sites of IP3 action.

Authors:  J Meldolesi; A Villa; P Volpe; T Pozzan
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1992

Review 2.  Calreticulin.

Authors:  M Michalak; R E Milner; K Burns; M Opas
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Expression of Ca2+ binding proteins of the sarcoplasmic reticulum of striated muscle in the endoplasmic reticulum of pig smooth muscles.

Authors:  L Raeymaekers; J Verbist; F Wuytack; L Plessers; R Casteels
Journal:  Cell Calcium       Date:  1993-09       Impact factor: 6.817

Review 5.  Ryanodine receptors: how many, where and why?

Authors:  V Sorrentino; P Volpe
Journal:  Trends Pharmacol Sci       Date:  1993-03       Impact factor: 14.819

6.  Subcellular-membrane characterization of [3H]ryanodine-binding sites in smooth muscle.

Authors:  Z D Zhang; C Y Kwan; E E Daniel
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

7.  Intracellular Ca2+ stores in chicken Purkinje neurons: differential distribution of the low affinity-high capacity Ca2+ binding protein, calsequestrin, of Ca2+ ATPase and of the ER lumenal protein, Bip.

Authors:  A Villa; P Podini; D O Clegg; T Pozzan; J Meldolesi
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

8.  The endoplasmic-sarcoplasmic reticulum of smooth muscle: immunocytochemistry of vas deferens fibers reveals specialized subcompartments differently equipped for the control of Ca2+ homeostasis.

Authors:  A Villa; P Podini; M C Panzeri; H D Söling; P Volpe; J Meldolesi
Journal:  J Cell Biol       Date:  1993-06       Impact factor: 10.539

9.  Inositol 1,4,5-trisphosphate receptor in heart: evidence for its concentration in Purkinje myocytes of the conduction system.

Authors:  L Gorza; S Schiaffino; P Volpe
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

10.  Characterization study of the ryanodine receptor and of calsequestrin isoforms of mammalian skeletal muscles in relation to fibre types.

Authors:  E Damiani; A Margreth
Journal:  J Muscle Res Cell Motil       Date:  1994-04       Impact factor: 2.698

View more
  7 in total

Review 1.  Intracellular organelles in the saga of Ca2+ homeostasis: different molecules for different purposes?

Authors:  Enrico Zampese; Paola Pizzo
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

2.  The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2).

Authors:  Guy Katz; Asher Shainberg; Edith Hochhauser; Efrat Kurtzwald-Josefson; Ahuva Issac; Dalia El-Ani; Dan Aravot; Arnon Afek; Jonathan G Seidman; Christine E Seidman; Michael Eldar; Michael Arad
Journal:  Biochem Pharmacol       Date:  2013-09-23       Impact factor: 5.858

3.  Reduced expression of Ca2+-regulating proteins in the upper gastrointestinal tract of patients with achalasia.

Authors:  Harald Fischer; Judith Fischer; Peter Boknik; Ulrich Gergs; Wilhelm Schmitz; Wolfram Domschke; Jan W Konturek; Joachim Neumann
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

4.  Mechanisms underlying angiotensin II-induced calcium oscillations.

Authors:  Aurélie Edwards; Thomas L Pallone
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18

5.  Calsequestrins in skeletal and cardiac muscle from adult Danio rerio.

Authors:  Sandra Furlan; Simone Mosole; Marta Murgia; Nagarjuna Nagaraj; Francesco Argenton; Pompeo Volpe; Alessandra Nori
Journal:  J Muscle Res Cell Motil       Date:  2015-11-20       Impact factor: 2.698

Review 6.  Calsequestrin: a well-known but curious protein in skeletal muscle.

Authors:  Jin Seok Woo; Seung Yeon Jeong; Ji Hee Park; Jun Hee Choi; Eun Hui Lee
Journal:  Exp Mol Med       Date:  2020-12-07       Impact factor: 8.718

7.  Differential localization and functional role of calsequestrin in growing and differentiated myoblasts.

Authors:  M Raichman; M C Panzeri; E Clementi; P Papazafiri; M Eckley; D O Clegg; A Villa; J Meldolesi
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.